Spectral AI updates on regulatory progress; expects UK DeepView revenue in H2 2024

Spectral AI, Inc.

Submitted DeepView AI-Burn for UKCA marking; response expected 1H 2024; first UK revenue in H2 2024.
BARDA awarded $149M contract in Sept 2023, total BARDA awards over $250M; $55M for development through Q1 2026.
Initiated pivotal US burn study with 240 subjects; FDA submission for burn indication expected 1H 2025.
DFU validation study continues; FDA application for DFU indication anticipated in late 2024.
Closed $10M Committed Equity Facility with B. Riley; appointed Pete Carlson as CFO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.